211 related articles for article (PubMed ID: 30146727)
1. A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
Pihlstrøm L; Blauwendraat C; Cappelletti C; Berge-Seidl V; Langmyhr M; Henriksen SP; van de Berg WDJ; Gibbs JR; Cookson MR; ; ; Singleton AB; Nalls MA; Toft M
Ann Neurol; 2018 Jul; 84(1):117-129. PubMed ID: 30146727
[TBL] [Abstract][Full Text] [Related]
2. SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
Cheng L; Wang L; Li NN; Yu WJ; Sun XY; Li JY; Zhou D; Peng R
J Neurol Sci; 2016 Sep; 368():231-4. PubMed ID: 27538639
[TBL] [Abstract][Full Text] [Related]
3. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.
Ding H; Sarokhan AK; Roderick SS; Bakshi R; Maher NE; Ashourian P; Kan CG; Chang S; Santarlasci A; Swords KE; Ravina BM; Hayes MT; Sohur US; Wills AM; Flaherty AW; Unni VK; Hung AY; Selkoe DJ; Schwarzschild MA; Schlossmacher MG; Sudarsky LR; Growdon JH; Ivinson AJ; Hyman BT; Scherzer CR
Mov Disord; 2011 Oct; 26(12):2283-6. PubMed ID: 21953863
[TBL] [Abstract][Full Text] [Related]
4. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
[TBL] [Abstract][Full Text] [Related]
5. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
[TBL] [Abstract][Full Text] [Related]
6. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
Pihlstrøm L; Berge V; Rengmark A; Toft M
Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
[TBL] [Abstract][Full Text] [Related]
8. Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies.
Krohn L; Wu RYJ; Heilbron K; Ruskey JA; Laurent SB; Blauwendraat C; Alam A; Arnulf I; Hu MTM; Dauvilliers Y; Högl B; Toft M; Bjørnarå KA; Stefani A; Holzknecht E; Monaca CC; Abril B; Plazzi G; Antelmi E; Ferini-Strambi L; Young P; Heidbreder A; Cochen De Cock V; Mollenhauer B; Sixel-Döring F; Trenkwalder C; Sonka K; Kemlink D; Figorilli M; Puligheddu M; Dijkstra F; Viaene M; Oertel W; Toffoli M; Gigli GL; Valente M; Gagnon JF; Nalls MA; Singleton AB; ; Desautels A; Montplaisir JY; Cannon P; Ross OA; Boeve BF; Dupré N; Fon EA; Postuma RB; Pihlstrøm L; Rouleau GA; Gan-Or Z
Ann Neurol; 2020 Apr; 87(4):584-598. PubMed ID: 31976583
[TBL] [Abstract][Full Text] [Related]
9. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.
Sotiriou S; Gibney G; Baxevanis AD; Nussbaum RL
Neurosci Lett; 2009 Sep; 461(2):196-201. PubMed ID: 19540308
[TBL] [Abstract][Full Text] [Related]
12. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
13. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
Guella I; Evans DM; Szu-Tu C; Nosova E; Bortnick SF; ; Goldman JG; Dalrymple-Alford JC; Geurtsen GJ; Litvan I; Ross OA; Middleton LT; Parkkinen L; Farrer MJ
Ann Neurol; 2016 Jun; 79(6):991-9. PubMed ID: 27091628
[TBL] [Abstract][Full Text] [Related]
14. SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.
Blažeković A; Jerčić KG; Borovečki F
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944443
[TBL] [Abstract][Full Text] [Related]
15. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.
McCarthy JJ; Linnertz C; Saucier L; Burke JR; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
Neurogenetics; 2011 Feb; 12(1):59-64. PubMed ID: 21046180
[TBL] [Abstract][Full Text] [Related]
16. Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9.
Lu S; Zhou J
Neurosci Bull; 2017 Feb; 33(1):115-117. PubMed ID: 27743341
[TBL] [Abstract][Full Text] [Related]
17. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
19. A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.
Cardo LF; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Pastor P; Samaranch L; Mata IF; Díaz M; Moris G; Menéndez M; Corao AI; Alvarez V
J Mol Neurosci; 2012 Jul; 47(3):425-30. PubMed ID: 22076805
[TBL] [Abstract][Full Text] [Related]
20. Genomic investigation of alpha-synuclein multiplication and parkinsonism.
Ross OA; Braithwaite AT; Skipper LM; Kachergus J; Hulihan MM; Middleton FA; Nishioka K; Fuchs J; Gasser T; Maraganore DM; Adler CH; Larvor L; Chartier-Harlin MC; Nilsson C; Langston JW; Gwinn K; Hattori N; Farrer MJ
Ann Neurol; 2008 Jun; 63(6):743-50. PubMed ID: 18571778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
